Target intelligence / Profile preview

Acetyl-coenzyme A thioesterase (ACOT12)

Target
ACOT12
Molecular classification
Enzyme, Thioesterase, Hydrolase
01

Overview

Acetyl-coenzyme A thioesterase (ACOT12) is an enzyme that catalyzes the hydrolysis of acetyl-CoA and related thioesters to free CoA and the corresponding acid, playing an essential role in regulating intracellular acetyl-CoA levels and lipid metabolism. It is a member of the acyl-CoA thioesterase enzyme family and is responsible for maintaining the cytosolic pool of acetyl-CoA in the liver and possibly other tissues. ACOT12 is structurally characterized by two thioesterase domains, with binding site selectivity for short-chain acyl-CoAs, especially acetyl-CoA, and its activity is allosterically modulated by intracellular lipid metabolites and energy charge (ATP/ADP). Biological consequences of altered ACOT12 activity extend to fatty acid synthesis, gluconeogenesis, ketone body metabolism, and eicosanoid signaling. Dysregulation is linked to metabolic disease, inflammation, and potentially cancer, making it an emerging though underexplored therapeutic target.

Other names
Acyl-CoA thioesterase 12ACOT12Acetyl-CoA hydrolaseAcetyl-CoA thioester hydrolaseCytosolic acyl-CoA thioesterase
02

Mechanism of action

Enzyme inhibition: Blocking ACOT12 prevents hydrolysis of acetyl-CoA, elevating its intracellular concentration; Enzyme activation: Increasing ACOT12 activity lowers cellular acetyl-CoA, affecting downstream lipid metabolic pathways

03

Biological functions

Regulation of acetyl-CoA and acyl-CoA levelsLipid metabolismFatty acid synthesis and degradationCellular energy regulation
04

Disease associations

Metabolic diseases (e.g., obesity, diabetes, fatty liver disease)InflammationPotential role in cancer through lipid metabolism regulationOther (as a lipid metabolism regulator)
05

Safety considerations

Disrupting acetyl-CoA homeostasis could have broad effects on energy metabolism, hepatic function, and possibly neurological and cardiovascular healthPossible off-target effects due to family redundancy (multiple acyl-CoA thioesterases with overlapping functions)
06

Interacting drugs

No widely approved small molecule drugs specifically target ACOT12 for therapy; research molecules and inhibitors exist (e.g., phosphatidic acid and lysophosphatidic acid act as endogenous inhibitors)
07

Biomarkers

No standardized clinical biomarkers for patient selection, but acetyl-CoA levels or abnormal lipid profiles may inform on ACOT12 activity/function

Beyond the preview

Go deeper on Acetyl-coenzyme A thioesterase (ACOT12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetyl-coenzyme A thioesterase (ACOT12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call